Processa Pharmaceuticals Files 8-K

Ticker: PCSA · Form: 8-K · Filed: Jul 18, 2025 · CIK: 1533743

Processa Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyProcessa Pharmaceuticals, Inc. (PCSA)
Form Type8-K
Filed DateJul 18, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-actions, financial-reporting

TL;DR

Processa Pharma filed an 8-K on 7/18/25 for shareholder votes and financials.

AI Summary

Processa Pharmaceuticals, Inc. filed an 8-K on July 18, 2025, reporting on the submission of matters to a vote of security holders and financial statements/exhibits. The company, formerly known as Heatwurx, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations industry.

Why It Matters

This filing indicates key corporate actions and financial reporting by Processa Pharmaceuticals, Inc., which could impact investors and stakeholders.

Risk Assessment

Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating immediate significant risk.

Key Numbers

  • 001-39531 — SEC File Number (Identifies the company's filing with the SEC)
  • 45-1539785 — IRS Employer Identification No. (Company's tax identification number)

Key Players & Entities

  • Processa Pharmaceuticals, Inc. (company) — Registrant
  • Heatwurx, Inc. (company) — Former company name
  • July 18, 2025 (date) — Date of report
  • Delaware (jurisdiction) — State of incorporation

FAQ

What specific matters were submitted to a vote of security holders?

The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in this excerpt.

What financial statements and exhibits are included in this filing?

The filing lists 'Financial Statements and Exhibits' as an item, but the specific content of these statements and exhibits is not detailed in this excerpt.

What is the principal executive office address for Processa Pharmaceuticals, Inc.?

The principal executive offices are located at 601 21st Street, Suite 300, Vero Beach, FL 32960.

What is the business phone number for Processa Pharmaceuticals, Inc.?

The business phone number is (772) 453-.

When did Processa Pharmaceuticals, Inc. change its name from Heatwurx, Inc.?

The company changed its name from Heatwurx, Inc. on October 28, 2011.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 18, 2025 regarding Processa Pharmaceuticals, Inc. (PCSA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.